Newsfeeds - Spark Newswire

2 minute read

Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court

Today, 3:09 AM

Clinical-stage biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) filed a lawsuit against drug discovery business Mindset Pharma Inc. (OTCQB: MSSTF) in the District Court of New Jersey.

MSSTF

1 minute read

Reported Late Monday March 13, Reunion Neuroscience Files Lawsuit Against Mindset Pharma Alleging That Mindset Knowingly Copied Reunion’s RE104 Compound And Misleadingly Presented That Exact Composition To The Patent Office As Mindset’s Invention

By Happy Mohamed

Today, 3:09 AM

Reunion Neuroscience Inc. (NASDAQ:REUN, TSX:REUN) ("Reunion"

REUN

3 minute read

Legal
News

‘Oklahoma House Approves Psilocybin Bill Protecting Patients From Prosecution And Promoting Research’ – Marijuana Moment

By Happy Mohamed

Today, 3:09 AM

https://www.marijuanamoment.net/oklahoma-house-approves-psilocybin-bill-protecting-patients-from-prosecution-and-promoting-research/ The Oklahoma House of Representatives has approved a bill to promote research into the

CMPS

4 minute read

Legal
News

‘Hawaii Senate Approves Marijuana Legalization And Psychedelic Research Bills’ – Marijuana Moment

By Happy Mohamed

Today, 3:09 AM

https://www.marijuanamoment.net/hawaii-senate-approves-marijuana-legalization-and-psychedelic-research-bills/

ACB

6 minute read

Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More

By Lara Goldstein

Today, 3:09 AM

Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and added to the list of measures calling for some sort of psychedelics legalization, while some of the already filed ones continue progressing and others get a thumbs down.

AGNPF

1 minute read

Reunion Neuroscience Q3 EPS $(1.07) Misses $(0.27) Estimate, Cash Balance Of $32.4M

By Benzinga Newsdesk

Today, 3:09 AM

Reunion Neuroscience (NASDAQ:REUN) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.27) by 296.3 percent. This is a 109.8 percent decrease over losses of $(0.51) per share

REUN

8 minute read

Earnings

Earnings Scheduled For February 14, 2023

By Benzinga Insights

Today, 3:09 AM

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

ABNB

3 minute read

‘Hawaii Senators Approve Bill To Promote Research Into Psilocybin And MDMA Therapy’ – Marijuana Moment

By Happy Mohamed

Today, 3:09 AM

https://www.marijuanamoment.net/hawaii-senators-approve-bill-to-promote-research-into-psilocybin-and-mdma-therapy/ Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of

CMPS

1 minute read

‘Hawaii Senate Committee Approves Bill To Create Therapeutic Psilocybin Working Group’ -Marijuana Moment Report

By Benzinga Newsdesk

Today, 3:09 AM

https://www.marijuanamoment.net/hawaii-senate-committee-approves-bill-to-create-therapeutic-psilocybin-working-group/

CMPS

2 minute read

‘Change To Classification Of Psilocybin And MDMA To Enable Prescribing By Authorized Psychiatrists’; Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change – Australian Government Department Of Health And Aged Care

By Happy Mohamed

Today, 3:09 AM

https://www.tga.gov.au/news/media-releases/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA

CMPS